Stay updated on RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Sign up to get notified when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.

Latest updates to the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page
- Check2 days agoChange DetectedThe site footer/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor platform or release update rather than a change to the study record details.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a metadata/version update with no visible changes to study content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the page's revision history. This update is an administrative versioning change and does not affect study details or eligibility criteria.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2 in the header/footer.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now displays Revision: v3.4.2. The funding-lapse notice and the prior Revision: v3.4.1 text have been removed.SummaryDifference0.4%

- Check81 days agoChange DetectedA site-wide notice about government funding lapse and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.